Zinc Finger Protein 265 (Zranb2) Peptide
Zranb2
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all ZNF265 (Zranb2) products
- ZNF265 (Zranb2) (Zinc Finger Protein 265 (Zranb2))
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-ZNF265 antibody (Catalog #: ARP37747_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- ZNF265 (Zranb2) (Zinc Finger Protein 265 (Zranb2))
- 背景
-
ZNF265 is a protein that has been shown to bind to the spliceosomal components U1-70K and U2AF35 and to direct alternative splicing. Analysis of the structure reveals substantial similarity to known RNA-binding motifs in terms of the distribution of key surface residues responsible for making RNA contacts, despite a complete lack of structural homology. An RNA gel shift assay was used to demonstrate that a single crossed finger domain from ZNF265 is capable of binding to an RNA message. Taken together, these results define a new RNA-binding motif and should provide insight into the functions of the >100 uncharacterized proteins in the sequence data bases that contain this domain.
Alias Symbols: ZIS, ZIS1, ZIS2, ZNF265
Protein Interaction Partner: EP300,SFRS12,SFRS17A,SMN2,SNRNP70,SRSF2,U2AF1,YY1,ZRANB2,ARRB1,SNRNP70,TRA2B,U2AF1,USP39
Protein Size: 330 - 分子量
- 37 kDa
- 基因ID
- 9406
- NCBI登录号
- NM_203350, NP_976225
- UniProt
- Q5VV34
-
You are here:
